<DOC>
	<DOCNO>NCT00995449</DOCNO>
	<brief_summary>The purpose study evaluate safety , pharmacokinetics ( PK ) , efficacy various repeat-dose regimen KB003 subject active Rheumatoid Arthritis ( RA ) inadequate prior treatment outcome biologic therapy .</brief_summary>
	<brief_title>Study KB003 In Biologics-Inadequate Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>At least 6 swollen least 6 tender joint Creactive Protein ( CRP ) &gt; Upper Limit Normal ( ULN ) Prior inadequate response biologic therapy Stable regimen concomitant RA therapy Unstable medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Biologics-Inadequate</keyword>
	<keyword>KB003</keyword>
	<keyword>GM-CSF</keyword>
</DOC>